Quanterix (QTRX) EBT Margin Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -300.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -287.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 233.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 772.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -464.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 584.00 |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn | 2,901.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,901.00 |
| Dec 31, 2025 | -1,883.00 |
| Sep 30, 2025 | -6,655.00 |
| Jun 30, 2025 | -10,178.00 |
| Mar 31, 2025 | -4,295.00 |
| Dec 31, 2024 | -561.00 |
| Sep 30, 2024 | -228.00 |
| Jun 30, 2024 | -389.00 |
| Mar 31, 2024 | -918.00 |
| Dec 31, 2023 | 4,239.00 |
| Sep 30, 2023 | 11,626.00 |
| Jun 30, 2023 | 9,665.00 |
| Mar 31, 2023 | 3,624.00 |
| Dec 31, 2022 | -1,059.00 |
| Sep 30, 2022 | -8,046.00 |
| Jun 30, 2022 | -6,718.00 |
| Mar 31, 2022 | -2,402.00 |
| Dec 31, 2021 | -2,123.00 |
| Sep 30, 2021 | -6,311.00 |
| Jun 30, 2021 | 4,710.00 |
| Mar 31, 2021 | 3,732.00 |
| Dec 31, 2020 | 3,146.00 |
| Sep 30, 2020 | 7,355.00 |
| Jun 30, 2020 | -1,596.00 |
| Mar 31, 2020 | 145.00 |
| Dec 31, 2019 | -27,295.00 |
| Sep 30, 2019 | 541.00 |
| Jun 30, 2019 | 709.00 |
| Mar 31, 2019 | 1,970.00 |
| Dec 31, 2018 | 31,108.00 |
| Sep 30, 2018 | 3,909.00 |
| Jun 30, 2018 | 3,913.00 |
| Mar 31, 2018 | 2,247.00 |